MedTrace Logo

Bioequivalence Study on Vitamin C in Healthy Adults

NCT03562988 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-08-23

Study results available
· View outcomes & findings →

Summary

The objective of this exploratory pharmacokinetic research study is to demonstrate that both caplets and gummies provide an effective dose of ascorbic acid in healthy adults.

Conditions

  • Dietary Exposure

Interventions

DIETARY_SUPPLEMENT

Vitamin C gummy

vitamin C

DIETARY_SUPPLEMENT

Vitamin C tablet

vitamin C

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Church & Dwight Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Annahita Ghassemi · Church & Dwight Company, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-12-22
Completion
2017-12-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03562988 on ClinicalTrials.gov